Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
money maze payment reimbursement

Medical home model designed to boost quality, reduce national healthcare costs is falling short

A redesigned patient-centered medical home approach focused on addressing high-value elements of care increased ED visits and had no effect on primary care spending, a new study shows.

Thumbnail

Patients waiting 5-plus hours in the ED before hospital admission face increased mortality risk

In fact, there was 1 extra death for every 82 individuals whose inpatient status was delayed 6-8 hours after arriving in the ED, population health experts reported this week.

overnight night shift attending radiologist burnout

Most doctors would trade a salary reduction for more free time

About 80% said they were happy prior to the pandemic, with about 6 in 10 now feeling that same way outside of work, according to new survey data.

dollar money graph increase finance

Investor-owned health systems and those with fewer PCPs linked to more low-value care

The JAMA Network Open analysis included more than 3,700 hospitals associated with 676 individual health systems.

Thumbnail

Mayo Clinic, Kaiser among health giants investing $110M into home care company

Baxter International, Global Medical Response and Cardinal Health also contributed capital to Boston-based Medically Home.

Thumbnail

Large hospital system’s ‘uncommon’ acquisition moves bolster patient outcomes, experience

Hospital consolidations have more than doubled since 2009 and most evidence suggests patients suffer as a result, NYU experts explained in JAMA Network Open.

Thumbnail

Centene clears regulatory requirements for $2.2B acquisition of Magellan Health

The deal is expected to be finalized in the coming days, the pair announced recently.

Thumbnail

New AI startup launches with $50M investment—former FDA commissioner named CEO

The company is focused on AI-powered blood tests that can potentially identify the early signs of cancer.